Novel Drug Delivery Systems for Cancer Therapy Market 2016-2020 report estimates the global novel drug delivery systems for cancer therapy market to reach nearly USD 12.8 Billion in 2020, at a CAGR of 18.4% from 2016 to 2020 – iHealthcareAnalyst, Inc.
Visit the Novel Drug Delivery Systems for Cancer Therapy Market 2016-2020 report https://www.ihealthcareanalyst.com/report/novel-drug-delivery-systems-cancer-therapy-market/
The global novel drug delivery systems for cancer therapy market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).
Novel drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. The novel drug delivery systems minimize drug degradation and loss, prevent harmful side-effects and increase drug bioavailability and the fraction of the drug accumulated in the required zone.
The global novel drug delivery systems for cancer therapy market segmentation is based on technology types such as embolization particles, drug eluting beads, PVA particles, microspheres, gelatin-based, selective internal radiation therapy (SIRT), TheraSphere, SIR-Spheres, Holmium-based Microspheres, Liquid Embolics, Onyx (LES and HD-500), TRUFILL nBCA LES, and nanoparticles. The global novel drug delivery systems for cancer therapy market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global novel drug delivery systems for cancer therapy market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
- Drug Eluting Beads
- PVA particles, microspheres, gelatin-based
- Selective Internal Radiation Therapy (SIRT)
- Holmium-based Microspheres
- Liquid Embolics
- Onyx (LES and HD-500)
- TRUFILL nBCA LES
- Geography (Region, Country)
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Rest of LA)
- Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
- Asia Pacific (Japan, China, India, Rest of APAC)
- Rest of the World
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.